125 related articles for article (PubMed ID: 1857350)
21. A comparison of methods for classifying samples as truly specific with confirmatory immunoassays.
Jaki T; Lawo JP; Wolfsegger MJ; Allacher P; Horling F
J Pharm Biomed Anal; 2014 Jan; 88():27-35. PubMed ID: 24013033
[TBL] [Abstract][Full Text] [Related]
22. Development of interferon-specific monoclonal antibody for in vitro interferon assays.
Meager A; Parti S; Webb K; Exley T
Dev Biol Stand; 1986; 64():237-48. PubMed ID: 3792649
[TBL] [Abstract][Full Text] [Related]
23. Exploring alternative hapten tethering sites for high-affinity anti-picoxystrobin antibody generation.
Parra J; Esteve-Turrillas FA; Abad-Somovilla A; Agulló C; Mercader JV; Abad-Fuentes A
Anal Biochem; 2011 Sep; 416(1):82-91. PubMed ID: 21651885
[TBL] [Abstract][Full Text] [Related]
24. Direct immunoassays and their performance - theoretical modelling of the effects of antibody orientation and associated kinetics.
Mackey D; Kelly E; Nooney R; O'Kennedy R
Integr Biol (Camb); 2018 Oct; 10(10):598-604. PubMed ID: 30187065
[TBL] [Abstract][Full Text] [Related]
25. Analysis of active antibody concentration. Separation of affinity and concentration parameters.
Karlsson R; Fägerstam L; Nilshans H; Persson B
J Immunol Methods; 1993 Nov; 166(1):75-84. PubMed ID: 8228289
[TBL] [Abstract][Full Text] [Related]
26. Theoretical analysis of the Farr antibody assay with a computer model: importance of antigen concentration and antibody affinity.
Griswold WR; Nelson DP
J Immunoassay; 1984; 5(1-2):71-86. PubMed ID: 6715552
[TBL] [Abstract][Full Text] [Related]
27. Validation, calibration, and specificity of quantitative D-dimer assays.
Dempfle CE
Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
[TBL] [Abstract][Full Text] [Related]
28. Food allergen detection with biosensor immunoassays.
Yman IM; Eriksson A; Johansson MA; Hellenäs KE
J AOAC Int; 2006; 89(3):856-61. PubMed ID: 16792086
[TBL] [Abstract][Full Text] [Related]
29. Establishment of the first WHO Erythropoietin antibody reference panel: Report of an international collaborative study.
Wadhwa M; Mytych DT; Bird C; Barger T; Dougall T; Han H; Rigsby P; Kromminga A; Thorpe R;
J Immunol Methods; 2016 Aug; 435():32-42. PubMed ID: 27173074
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of immunoassay sensitivity by molecular modification of competitors.
Jockers R; Bier FF; Schmid RD
J Immunol Methods; 1993 Aug; 163(2):161-7. PubMed ID: 8354885
[TBL] [Abstract][Full Text] [Related]
31. Immunochemical analysis of water micropollution.
Aherne GW
Sci Total Environ; 1993 Aug; 135(1-3):73-9. PubMed ID: 8211103
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri®) with endogenous IgG4.
Shapiro RI; Plavina T; Schlain BR; Pepinsky RB; Garber EA; Jarpe M; Hochman PS; Wehner NG; Bard F; Motter R; Yednock TA; Taylor FR
J Pharm Biomed Anal; 2011 Apr; 55(1):168-75. PubMed ID: 21300512
[TBL] [Abstract][Full Text] [Related]
33. Theoretical assessments of errors in rapid immunoassays-how critical is the exact timing and reagent concentrations?
Ylander PJ; Bicskei Z; Hänninen P; Soini JT
Biophys Chem; 2006 Sep; 123(2-3):141-5. PubMed ID: 16750878
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneous enzyme immunoassay.
O'Beirne AJ; Cooper HR
J Histochem Cytochem; 1979 Aug; 27(8):1148-62. PubMed ID: 383822
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of dried blood spots for the quantification of therapeutic monoclonal antibodies and detection of anti-drug antibodies.
Kaendler K; Warren A; Lloyd P; Sims J; Sickert D
Bioanalysis; 2013 Mar; 5(5):613-22. PubMed ID: 23425276
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of haptens and selective enzyme-linked immunosorbent assay of octachlorostyrene.
Shi L; Zhou L; Dai G; Wang N; An D; Cai Q
Talanta; 2013 Oct; 115():386-93. PubMed ID: 24054607
[TBL] [Abstract][Full Text] [Related]
37. HLA antibody detection and characterization by solid phase immunoassays: methods and pitfalls.
Zachary AA; Vega RM; Lucas DP; Leffell MS
Methods Mol Biol; 2012; 882():289-308. PubMed ID: 22665241
[TBL] [Abstract][Full Text] [Related]
38. Validation of a quantitative flow cytometer assay for monitoring HER-2/neu expression level in cell-based cancer immunotherapy products.
Randlev B; Huang LC; Watatsu M; Marcus M; Lin A; Shih SJ
Biologicals; 2010 Mar; 38(2):249-59. PubMed ID: 20080049
[TBL] [Abstract][Full Text] [Related]
39. Theoretical analysis of the sensitivity of the solid phase antibody assay (ELISA).
Griswold WR
Mol Immunol; 1987 Dec; 24(12):1291-4. PubMed ID: 2448607
[TBL] [Abstract][Full Text] [Related]
40. Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparison.
Barger TE; Kuck AJ; Chirmule N; Swanson SJ; Mytych DT
Nephrol Dial Transplant; 2012 Feb; 27(2):688-93. PubMed ID: 21602184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
